Clinical trial
Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms
NCT04351763 is registered in ClinicalTrials.gov with Nicolaus Copernicus University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms
- Lead sponsor
- Nicolaus Copernicus University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 20, 2020
- Completion date
- June 5, 2021
- Enrollment
- 804 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.